← Back to Search

Robotic Arm Therapy for Stroke

Phase 1
Waitlist Available
Led By Lauren McDonagh, PT
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Head, neck, and trunk control to maintain an upright posture for a minimum of 45 minutes
Active shoulder flexion and/or abduction greater than 30 degrees
Must not have
Contractures in the involved upper extremity at the shoulder, elbow, or wrist
Unstable cardiovascular orthopedic or neurological conditions that would preclude exercise in short-duration, high work-load trials
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether adding robotic therapy to standard occupational therapy can help stroke patients recover arm movement faster and more accurately.

Who is the study for?
This trial is for right-handed individuals aged 65-84 who've had a right hemisphere ischemic stroke within the last 15 days, leading to arm weakness. They must be able to follow commands and maintain an upright posture for at least 45 minutes with some shoulder movement and elbow flexion. Those with previous strokes, certain types of stroke, severe muscle tone issues or contractures, full limb movement, poor vision, or unstable health conditions that affect exercise cannot join.
What is being tested?
The study compares standard occupational therapy against a mix of conventional therapy and robotic assistance using the Reo Go device. This device aims to improve arm function in acute stroke patients by helping them perform more precise movements during rehabilitation.
What are the potential side effects?
While not explicitly mentioned here, potential side effects may include discomfort from repetitive movements or fatigue due to intensive training sessions with the robotic arm trainer.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can sit up straight without support for at least 45 minutes.
Select...
I can lift my arm above 30 degrees without help.
Select...
I am right-handed and between 65-84 years old.
Select...
I had a stroke in the right side of my brain less than 15 days ago, causing arm weakness.
Select...
I can bend my elbow at least 45 degrees.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have stiffness in my arm that limits movement.
Select...
I don't have heart, bone, or nerve conditions that stop me from doing intense short exercises.
Select...
I have moderate to severe stiffness in my arm.
Select...
I can fully move my arm by itself without help.
Select...
I have had a stroke before.
Select...
I have had a stroke involving bleeding in the brain.
Select...
I can follow directions and track visual targets without difficulty.
Select...
My arm is weak and cannot move properly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Robotic and Conventional TherapyExperimental Treatment1 Intervention
Group II: Conventional TreatmentActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
183 Previous Clinical Trials
11,133 Total Patients Enrolled
Kessler Institute for RehabilitationIndustry Sponsor
22 Previous Clinical Trials
1,125 Total Patients Enrolled
Lauren McDonagh, PTPrincipal InvestigatorKessler Rehabilitation Institute

Media Library

Conventional Therapy Clinical Trial Eligibility Overview. Trial Name: NCT00785343 — Phase 1
Pediatric Hemiparesis Research Study Groups: Robotic and Conventional Therapy, Conventional Treatment
Pediatric Hemiparesis Clinical Trial 2023: Conventional Therapy Highlights & Side Effects. Trial Name: NCT00785343 — Phase 1
Conventional Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT00785343 — Phase 1
~2 spots leftby Dec 2025